BENEPALI

Shares of Biogen Inc (NASDAQ: BIIB) were trading higher by 2 percent at $279.00 early Tuesday morning after the company announced that the European Union has granted marketing authorization for its BENEPALI. BENEPALI is an etanercept biosimilar referencing Enbrel and is the first etanercept...